Advertisement

HNO

, Volume 58, Issue 10, pp 990–998 | Cite as

Zur Pharmakotherapie des akuten und chronischen Tinnitus

  • G. HesseEmail author
  • A. Laubert
Leitthema

Zusammenfassung

Die Ätiologie des akuten Tinnitus ist wie die des Hörsturzes in der Mehrzahl der Fälle als idiopathisch anzusehen; wesentlich seltener sind infektiöse oder vaskuläre Ursachen. In einer umfassenden Literaturrecherche werden Studien und Metaanalysen zur Pharmakotherapie ausgewertet: Für den chronischen Tinnitus sind medikamentöse Therapien nicht indiziert, allenfalls werden begleitende, etwa psychosomatische Komorbidiäten mit Psychopharmaka behandelt. Beim akuten Tinnitus wird analog der Hörsturzbehandlung trotz schwacher Evidenz nach ausbleibender Spontanerholung eine Behandlung mit Glukokortikoiden und initial mit Volumenersatzmitteln empfohlen. Als Reservetherapie eignet sich, jedenfalls bei starkem Hörverlust und akutem Tinnitus, eine intratympanale Steroidbehandlung.

Schlüsselwörter

Tinnitus Hörsturz Hörminderung, sensorineurale Pharmakotherapie Intratympanale Steroidbehandlung 

Pharmacotherapy of acute and chronic hearing loss

Abstract

The aetiology of acute hearing loss is mostly idiopathic like sudden sensorineural hearing loss and rarely infectious or vascular. Several studies and meta-analyses of pharmacotherapy are reviewed: In chronic tinnitus there is no indication for pharmacotherapy; sometimes a possible psychosomatic comorbidity has to be treated with psychopharmaceutical agents. Despite a low level of evidence treatment with steroids and initially plasma expanding infusions is recommended for acute tinnitus if there is no spontaneous remission. Intratympanic steroid therapy can be used as an alternative if there is severe hearing loss together with tinnitus.

Keywords

Tinnitus Hearing loss, sudden Hearing loss, sensorineural Pharmacotherapy Intratympanic steroidal therapy 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    AWMF (2010) Leitlinie „Tinnitus“. Leitlinien der Dtsch. Ges. f. Hals-Nasen-Ohren-Heilkunde, Kopf- und Halschirurgie, Leitlinie 017/064:1–16Google Scholar
  2. 2.
    Bakhshaee M, Ghasemi M, Azarpazhooh M et al (2007) Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study. Eur Arch Otorhinolaryngol 25:Epub ahead of printGoogle Scholar
  3. 3.
    Bauer C, Brozoski T (2006) Effect of gabepentin on the sensation and impact of tinnitus. Laryngoscope 116:675–681CrossRefPubMedGoogle Scholar
  4. 4.
    Bennett M, Kertesz T, Yeung P (2007) Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 24:CD004739Google Scholar
  5. 5.
    Canis M, Olzowy B, Welz C et al (2009) Simvastin and Ginkgo biloba in the treatment of subacute tinnitus: a retrospective study of 94 patients. Am J Otolaryngol 30:Epub ahead of printGoogle Scholar
  6. 6.
    Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD (2009) Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 120:1011–1021Google Scholar
  7. 7.
    Cinamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 258:477–480CrossRefPubMedGoogle Scholar
  8. 8.
    Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 133:573–581CrossRefPubMedGoogle Scholar
  9. 9.
    Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: II. A Metaanalysis. Arch Otolaryngol Head Neck Surg 133:582–586CrossRefPubMedGoogle Scholar
  10. 10.
    Dallan I, De Vito A, Fattori B et al (2010) Intratympanic methylprednisolone in refractory sudden hearing loss: A 27-patient case series with univariate and multivariate analysis. Otol Neurotol 31:25–30CrossRefPubMedGoogle Scholar
  11. 11.
    De Azevedo A, Langguth B, De Oliveira P et al (2009) Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. Otol Neurotol 30:676–680CrossRefGoogle Scholar
  12. 12.
    Gong Y, Liang C, Li J, Tian A, Chen N (2002) Vasodilators for sudden sensorineural hearing loss: a systematic review of randomized controlled trials. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 37:64–68Google Scholar
  13. 13.
    Heiden C, Porzsolt F, Biesinger E et al (2000) Die Spontanheilung des Hörsturzes. HNO 48:621–623CrossRefPubMedGoogle Scholar
  14. 14.
    Hesse G, Andres R, Schaaf H et al (2008) DPOAE und laterale Inhibition bei chronischem Tinnitus. HNO 56:694–700CrossRefPubMedGoogle Scholar
  15. 15.
    Khan M, Amarjargal N, Gross J et al (2007) Coenzyme Q10 does not protect cochlear hair cells form death in the ischemic organotypic culture. Otolaryngol Head Neck Surg 137:950–952CrossRefPubMedGoogle Scholar
  16. 16.
    Khan M, Gross J, Haupt H et al (2007) A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium. Otolaryngol Head Neck Surg 136:72–77CrossRefPubMedGoogle Scholar
  17. 17.
    Klemm E, Bepperling F, Burschka MA et al (2007) Hemodilution therapy with hydroxyethyl starch solution (130/0,4) in unilateral idiopathic sudden sensorineural hearing loss: A dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients. Otol Neurotol 28:157–170CrossRefPubMedGoogle Scholar
  18. 18.
    Lamm K (1995) Rationale Grundlagen einer Innenohrtherapie. Otorhinolaryngol Nova 5:153–160CrossRefGoogle Scholar
  19. 19.
    Laubert A (2008) Therapie des akuten Tinnitus. In: Hesse G (Hrsg) Tinnitus. Thieme, Stuttgart New York, S 62–72Google Scholar
  20. 20.
    Mazurek B, Haupt H, Gross J (2006) Pharmakotherapie des akuten Tinnitus. HNO 54:9–15CrossRefPubMedGoogle Scholar
  21. 21.
    Mazurek B, Haupt H, Szczepek A et al (2009) Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study. J Negat Results Biomed 8:3CrossRefPubMedGoogle Scholar
  22. 22.
    Michel O, Jahns T, Joost-Enneking M et al (2000) Das antiphlogistisch-rheologische Infusionsschema nach Stennert in der Behandlung von kochleovestibulären Störungen. HNO 48:182–188CrossRefPubMedGoogle Scholar
  23. 23.
    Mikulec A, Plontke S, Hartsock J et al (2009) Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol 30:131–138CrossRefPubMedGoogle Scholar
  24. 24.
    Mösges R, Köberlein J, Heibges A et al (2009) Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 266:943–953CrossRefPubMedGoogle Scholar
  25. 25.
    Olzowy B Cm, Hempel JM, Mazurek B, Suckfüll M (2007) Effect of atorvastin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial. Otol Neurotol 28:455–458CrossRefPubMedGoogle Scholar
  26. 26.
    Plontke S, Löwenheim H, Mertens J et al (2009) Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexmethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 119:359–369CrossRefPubMedGoogle Scholar
  27. 27.
    Reimann S, Szépfalusi Z, Kraft D et al (2000) Hydroxyethyl starch accumulation in the skin with special reference to hydroxyethyl starch-assosciated pruritus. Dtsch Med Wochenschr 125:280–285CrossRefPubMedGoogle Scholar
  28. 28.
    Salt A, Plontke S (2009) Principles of local drug delivery to the inner ear. Audiol Neurootol 14:350–360CrossRefPubMedGoogle Scholar
  29. 29.
    Schaaf H (2008) Psychosomatik. In: Hesse G (Hrsg) Tinnitus. Thieme, Stuttgart New York, S 93–112Google Scholar
  30. 30.
    Schaaf H, Klofat B, Hesse G (2003) Hyperakusis, Phonophobie und Recruitment. HNO 51:1005–1011CrossRefPubMedGoogle Scholar
  31. 31.
    Schwab B, Lenarz T, Heermann R (2004) Der Round Window µCath zur Lokaltherapie des Innenohres – Ergebnisse einer plazebokontrollierten, prospektiven Studie bei chronischem Tinnitus. Laryngorhinootologie 83:164–172CrossRefPubMedGoogle Scholar
  32. 32.
    Suckfüll M (2002) Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360:1811–1817CrossRefPubMedGoogle Scholar
  33. 33.
    Topak M, Sahin-Yilmaz A, Ozdoganoglu T et al (2009) Intratympanic methylprednisolone injections for subjective tinnitus. J Laryngol Otol 29:1–5Google Scholar
  34. 34.
    Uygun-Kiehne S, Straube R, Heibges A et al (2010) Rheopherese bei rezidivierendem Hörsturz. HNO 58:445–451CrossRefPubMedGoogle Scholar
  35. 35.
    Wei BP Mubiru S, O’Leary S (2006) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 25:CD003998Google Scholar
  36. 36.
    Weinaug P (1985) Zur Therapie des Hörsturzes und des isolierten einseitigen Vestibularisausfalles. Laryngorhinootologie 64:347–350CrossRefGoogle Scholar
  37. 37.
    Wilhelm T, Agababov V, Lenarz T (2001) Rheologische Infusionstherapie, Neurotransmitterapplikation und Lidocain-Injektion bei Tinnitus. HNO 49:93–101CrossRefPubMedGoogle Scholar
  38. 38.
    Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss: A double-blind clinical study. Arch Otolaryngol 106(12):772–776PubMedGoogle Scholar
  39. 39.
    Witsell DL, Hannley MT, Stinnet S et al (2006) Treatment of tinnitus with gabapentin: A pilot study. Otol Neurotol 28:11–15CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Tinnitus-KlinikKrankenhaus Bad ArolsenBad ArolsenDeutschland
  2. 2.HNO-Klinik der Kath. Krankenhaus Hagen gGmbHHNO-Lehrstuhl der Universität Witten-HerdeckeWitten-HerdeckeDeutschland

Personalised recommendations